Heartburn during pregnancy and lactation should be managed with lifestyle modifications, and physicians must discuss with the patient risks and benefits of medications in cases where disease severity increases, according to a recent review.
Intravenous (IV) infusion of iron isomaltoside led to a significantly reduced incidence of hypophosphatemia in patients with iron deficiency anaemia (IDA) compared with ferric carboxymaltose, according to results of two randomized clinical trials.
A vegan diet among pregnant women appears to have no impact on the umbilical-cord levels of vitamin B12, folate, ferritin and haemoglobin, according to a study presented at the 2020 Annual Meeting of the Society for Maternal-Fetal Meeting (SMFM 2020).
Pregnant women with urinary tract infections (UTIs) caused by multidrug-resistant (MDR) bacteria may be at increased risk of developing pyelonephritis, according to a single-centre, retrospective study presented at SMFM 2020.
Elevated levels of human chorionic gonadotropin (hCG) as well as a history of depression and increased depressive symptoms in the twelfth to fourteenth week of gestation contribute to a higher likelihood of having nausea and vomiting during pregnancy (NVP), a study has found.
Pregnant women with inadequate knowledge on health are more likely to have undesirable maternal outcomes during delivery and adverse outcomes in their offspring than those who were well informed, according to a large cohort study presented at SMFM 2020 Annual Pregnancy Meeting.
A diet low in fat and high in fibre seems well tolerated in patients with ulcerative colitis, not contributing to increased inflammation while significantly increasing populations of Faecalibacterium prausnitzii, according to a study presented at the 2020 Crohn's & Colitis Congress.
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.